Search hospitals > California > Fresno
Fresno Cancer Center
Claim this profileFresno, California 93720
Global Leader in Breast Cancer
Conducts research for Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Breast cancer
Conducts research for Cancer
81 reported clinical trials
6 medical researchers
Summary
Fresno Cancer Center is a medical facility located in Fresno, California. This center is recognized for care of Breast Cancer, Prostate Cancer, Lung Cancer, Breast cancer, Cancer and other specialties. Fresno Cancer Center is involved with conducting 81 clinical trials across 142 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Natalya Greyz-Yusupov.Area of expertise
1Breast Cancer
Global LeaderStage I
Stage II
Stage III
2Prostate Cancer
Stage IV
Stage I
Stage II
Top PIs
Jennifer M. SugaKaiser Permanente-Oakland2 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
103 drugs studied
Tatjana Kolevska, MDKaiser Permanente-Vallejo2 years of reported clinical research
Studies Cancer
Studies Melanoma
22 reported clinical trials
52 drugs studied
Samantha A. SeawardKaiser Permanente Medical Center - Santa Clara3 years of reported clinical research
Studies Breast Cancer
Studies Prostate Cancer
22 reported clinical trials
63 drugs studied
Natalya Greyz-YusupovKaiser Permanente-Fresno6 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
7 reported clinical trials
13 drugs studied
Clinical Trials running at Fresno Cancer Center
Breast Cancer
Ovarian Cancer
Prostate Cancer
Cutaneous Melanoma
Esophageal cancer
Lung Cancer
Melanoma
Cancer
Esophageal Adenocarcinoma
Gastric cancer
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are being observed for cardiac toxicity. The largest cohort (currently open to accrual) is observational, and contains patients who are taking a beta blocker, ACE inhibitor, or ARB as well as their trastuzumab-based treatment. The goal is to understand how common cardiac problems are in this group of patients at high risk. The smaller cohort (currently closed to accrual) is randomized. Patients in this second cohort are randomized to either carvedilol or no treatment, with the goal of seeing whether carvedilol (used to treat heart failure and high blood pressure) may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Fresno Cancer Center?
Fresno Cancer Center is a medical facility located in Fresno, California. This center is recognized for care of Breast Cancer, Prostate Cancer, Lung Cancer, Breast cancer, Cancer and other specialties. Fresno Cancer Center is involved with conducting 81 clinical trials across 142 conditions. There are 6 research doctors associated with this hospital, such as Jennifer M. Suga, Tatjana Kolevska, MD, Samantha A. Seaward, and Natalya Greyz-Yusupov.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.